Page last updated: 2024-08-24

plerixafor and Brucellosis

plerixafor has been researched along with Brucellosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arayan, LT; Huy, TXN; Kang, CK; Kim, S; Lee, HJ; Lee, JH; Min, W; Reyes, AWB; Vu, SH	1

Other Studies

1 other study(ies) available for plerixafor and Brucellosis

Article	Year
Chemokine receptor 4 (CXCR4) blockade enhances resistance to bacterial internalization in RAW264.7 cells and AMD3100, a CXCR4 antagonist, attenuates susceptibility to Brucella abortus 544 infection in a murine model. Veterinary microbiology, 2019, Volume: 237 Topics: Animals; Benzylamines; Brucella abortus; Brucellosis; Cell Survival; Cyclams; Disease Susceptibility; Female; Heterocyclic Compounds; Mice; Mice, Inbred BALB C; Models, Biological; RAW 264.7 Cells; Receptors, CXCR4; Specific Pathogen-Free Organisms	2019

Article

Year

Chemokine receptor 4 (CXCR4) blockade enhances resistance to bacterial internalization in RAW264.7 cells and AMD3100, a CXCR4 antagonist, attenuates susceptibility to Brucella abortus 544 infection in a murine model.

Veterinary microbiology, 2019, Volume: 237

Topics: Animals; Benzylamines; Brucella abortus; Brucellosis; Cell Survival; Cyclams; Disease Susceptibility; Female; Heterocyclic Compounds; Mice; Mice, Inbred BALB C; Models, Biological; RAW 264.7 Cells; Receptors, CXCR4; Specific Pathogen-Free Organisms

2019